Nedal Safwat
Corporate Officer/Principal chez QIAGEN N.V.
Profil
Nedal Safwat is currently the Director at Gradientech AB and also holds the position of VP & Head-Molecular Diagnostics North America at QIAGEN NV.
Previously, he worked as the Chief Strategy Officer at Accelerate Diagnostics, Inc. Mr. Safwat completed his undergraduate and doctorate degrees from North Carolina State University.
Postes actifs de Nedal Safwat
Sociétés | Poste | Début |
---|---|---|
QIAGEN N.V. | Corporate Officer/Principal | - |
Gradientech AB
Gradientech AB BiotechnologyHealth Technology Gradientech AB operates as biotech and diagnostics company. It develops and provides ultra-rapid antibiotic susceptibility testing products. The company's products include QuickMic, CellDirector and Tracking Tool PRO. Gradientech was founded by Sara Ulrika Thorslund and Johan Kreuger in 2009 and is headquartered in Uppsala, Sweden. | Director/Board Member | 09/05/2023 |
Anciens postes connus de Nedal Safwat
Sociétés | Poste | Fin |
---|---|---|
ACCELERATE DIAGNOSTICS, INC. | Corporate Officer/Principal | - |
Formation de Nedal Safwat
North Carolina State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ACCELERATE DIAGNOSTICS, INC. | Health Technology |
QIAGEN N.V. | Health Technology |
Entreprise privées | 1 |
---|---|
Gradientech AB
Gradientech AB BiotechnologyHealth Technology Gradientech AB operates as biotech and diagnostics company. It develops and provides ultra-rapid antibiotic susceptibility testing products. The company's products include QuickMic, CellDirector and Tracking Tool PRO. Gradientech was founded by Sara Ulrika Thorslund and Johan Kreuger in 2009 and is headquartered in Uppsala, Sweden. | Health Technology |